San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Breast Cancer Study Finds Pluses in Use of Proton Therapy

Despite its reputation for being expensive, proton cancer therapy may cost the same or less than other cancer therapies, according to a recent study using Medicare reimbursement codes.

Otonomy Inc. Reports Increased R&D Expenses in Q3

San Diego-based Otonomy Inc., a clinical-stage biopharmaceutical company developing treatments for the inner and middle ear, announced financial results for the third quarter of 2014.

Health Care Reset Button Will Get Pushed, But Not all the Way

While the election results ensure a new round of attacks on Obamacare, experts say a full repeal of the federal health care law is, well, impossible.

Tease photo

S.D. Firms Tackle Symptoms, Ebola Diagnostics

MEDICINE: The Cos. Have the Capacity for Ramping Up Production

Another San Diego-based company is taking aim at Ebola, but unlike the other companies, Leading BioSciences Inc. is focusing on treating the symptoms of the deadly virus rather than targeting the virus itself.

Receptos CEO Named Chairman of Tocagen's Board of Directors

Tocagen Inc., a clinical-stage company working on therapies that boost the immune response to cancer, announced that Faheem Hasnain, president and chief executive officer of Receptos Inc., has been appointed as chairman of the board of directors.

Sophiris Bio Inc. Reports Third Quarter Results

La Jolla-based Sophiris Bio Inc., a clinical stage biopharmaceutical company developing products for the treatment of urological diseases, announced its third quarter financial results.

Pfenex Inc. Reports Q3 Revenue of $2.8 Million

Pfenex Inc., a clinical-stage biotechnology company that makes biosimilars, including vaccines for anthrax and malaria, reported financial results for the third quarter that ended Sept. 30, 2014.

Mast Therapeutics Closes Underwritten Public Offering

Mast Therapeutics Inc., a clinical stage biopharmaceutical company, announced the closing of its underwritten public offering of $21 million in equity securities.

DJO Global Reports Q3 Net Sales of $305.5 Million

DJO Global Inc., the Vista manufacturer of orthopedic devices, reported third-quarter net sales of $305.5 million, up 6.1 percent from the net sales of the like quarter of 2013.

Haskell Construction Acquires Consultants FreemanWhite

Haskell, a national design, engineering and construction firm, announced it has acquired FreemanWhite, a Charlotte-based consulting and design practice focused exclusively on the health care sector. FreemanWhite has an office in San Diego.

Startup Wireless Diagnostics Systems Raises $500,000

Wireless Diagnostic Systems Inc., a San Diego startup developing patient monitoring devices with technology from the California Institute of Technology lab of Axel Scherer, raised $500,000 from Domain Associates, according to a recent regulatory filing.

Isis to Offer $425 Million of Convertible Senior Notes

Isis Pharmaceuticals Inc. announced Monday that it intends to offer $425 million of convertible senior notes, due in 2021, in a private placement, subject to market and other considerations.

Proton Cancer Therapy Less Costly Than Thought, Data Shows

Despite its reputation for being expensive, proton cancer therapy may cost the same or less than other cancer therapies, according to a recent study using Medicare reimbursement codes.

Carlsbad Biotech Gets FDA Clearance For Stem Cell Line

International Stem Cell Corp., a Carlsbad-based biotech company developing stem cell therapies and biomedical products, announced that the U. S. Food and Drug Administration has cleared the company’s human parthenogenetic stem cells line for investigational clinical use.

Co. Aims to Disrupt Health Care Temp-Staffing Model With Website

MEDICINE: Site Streamlines the Process, Eliminates Need for Broker

There are scores of staffing agencies nationwide that cater to doctors looking for temporary work and hospitals seeking part-time physicians.